4.8 Article

A SNAP25 promoter variant is associated with early-onset bipolar disorder and a high expression level in brain

期刊

MOLECULAR PSYCHIATRY
卷 15, 期 7, 页码 748-755

出版社

SPRINGERNATURE
DOI: 10.1038/mp.2008.148

关键词

SNAP-25; association study; bipolar affective disorder; attention-deficit hyperactivity disorder; expression study

资金

  1. INSERM
  2. National Alliance for Research on Schizophrenia and Affective Disorders
  3. Assistance Publique des Hopitaux de Paris
  4. Agence Nationale pour la Recherche (ANR) [NEURO2006]
  5. Fondation pour la Recherche sur le Cerveau
  6. Reseau Thematique de Recherche et de Soins en Sante Mentale (Fondation FondaMental)

向作者/读者索取更多资源

Bipolar disorder (BD) is one of the most common and persistent psychiatric disorders. Early-onset BD has been shown to be the most severe and familial form. We recently carried out a whole-genome linkage analysis on sibpairs affected by early-onset BD and showed that the 20p12 region was more frequently shared in our families than expected by chance. The synaptosomal-associated protein SNAP25 is a presynaptic plasma membrane protein essential for the triggering of vesicular fusion and neurotransmitter release, and for which abnormal protein levels have been reported in postmortem studies of bipolar patients. We hypothesised that variations in the gene encoding SNAP25, located on chromosome 20p12, might influence the susceptibility to early-onset BD. We screened SNAP25 for mutations and performed a case-control association study in 197 patients with early-onset BD, 202 patients with late-onset BD and 136 unaffected subjects. In addition, we analysed the expression level of the two SNAP25 isoforms in 60 brains. We showed that one variant, located in the promoter region, was associated with early-onset BD but not with the late-onset subgroup. In addition, individuals homozygous for this variant showed a significant higher SNAP25b expression level in prefrontal cortex. These results show that variations in SNAP25, associated with an increased gene expression level in prefrontal cortex, might predispose to early-onset BD. Further analyses of this gene, as well as analysis of genes encoding for the SNAP25 protein partners, are required to understand the impact of such molecular mechanisms in BD. Molecular Psychiatry (2010) 15, 748-755; doi:10.1038/mp.2008.148; published online 6 January 2009

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Psychology, Clinical

Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study

Victoria Rodriguez, Luis Alameda, Diego Quattrone, Giada Tripoli, Charlotte Gayer-Anderson, Edoardo Spinazzola, Giulia Trotta, Hannah E. Jongsma, Simona Stilo, Caterina La Cascia, Laura Ferraro, Daniele La Barbera, Antonio Lasalvia, Sarah Tosato, Ilaria Tarricone, Elena Bonora, Stephane Jamain, Jean-Paul Selten, Eva Velthorst, Lieuwe de Haan, Pierre-Michel Llorca, Manuel Arrojo, Julio Bobes, Miguel Bernardo, Celso Arango, James Kirkbride, Peter B. Jones, Bart P. Rutten, Alexander Richards, Pak C. Sham, Michael O'Donovan, Jim Van Os, Craig Morgan, Marta Di Forti, Robin M. Murray, Evangelos Vassos

Summary: This study suggests that combining polygenic risk scores (PRS) for severe psychiatric disorders with prediction models for psychosis phenotypes can improve discrimination ability and enhance our understanding of these phenotypes. PRS may have potential usefulness in specific populations such as those at high risk or in the early stages of psychosis.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychiatry

Telomere length and mitochondrial DNA copy number in bipolar disorder: A sibling study

Luana Spano, Bruno Etain, Jean-Louis Laplanche, Marion Leboyer, Sebastien Gard, Frank Bellivier, Cynthia Marie-Claire

Summary: This study finds consistency in cellular aging biomarkers between individuals with bipolar disorder and their siblings, suggesting shared environmental or genetic factors.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2023)

Article Clinical Neurology

Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression

Chiara C. Bortolasci, Srisaiyini Kidnapillai, Briana Spolding, Trang T. T. Truong, Timothy Connor, Courtney Swinton, Bruna Panizzutti, Zoe S. J. Liu, Andrew Sanigorski, Olivia M. Dean, Tamsyn Crowley, Mark Richardson, Kiymet Bozaoglu, Katerina Vlahos, Stephanie Cowdery, Brad Watmuff, Stephan F. Steyn, De Wet Wolmarans, Barend J. Engelbrecht, Christina Perry, Katherine Drummond, Terence Pang, Stephane Jamain, Laura Gray, Sean L. McGee, Brian H. Harvey, Jee Hyun Kim, Marion Leboyer, Michael Berk, Ken Walder

Summary: The aim of this study was to identify a drug for repurposing in the treatment of bipolar depression. A gene expression signature was generated using human neuronal-like cells to represent the effects of drugs used to treat bipolar disorder. Trimetazidine was identified as a potential candidate for repurposing based on its similar transcriptional effects and its ability to increase ATP production.

BIPOLAR DISORDERS (2023)

Article Clinical Neurology

Gene expression of circadian genes and CIART in bipolar disorder: A preliminary case-control study

Cindie Courtin, Cynthia Marie-Claire, Gregory Gross, Vincent Hennion, Emeline Mundwiller, Justine Guegan, Manon Meyrel, Frank Bellivier, Bruno Etain

Summary: Based on circadian rhythm disruptions and sleep abnormalities in bipolar disorder, a study investigated the expression levels of 19 circadian genes in individuals with BD and healthy controls. The results showed differences in the expression of four circadian genes between the two groups. This study opens avenues for further research combining expression and epigenetic analyses in larger samples.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2023)

Article Psychology, Clinical

Definition of early age at onset in bipolar disorder according to distinctive neurodevelopmental pathways: insights from the FACE-BD study

Filippo Corponi, Antoine Lefrere, Marion Leboyer, Frank Bellivier, Ophelia Godin, Josephine Loftus, Philippe Courtet, Caroline Dubertret, Emmanuel Haffen, Pierre Michel Llorca, Paul Roux, Mircea Polosan, Raymund Schwan, Ludovic Samalin, Emilie Olie, Bruno Etain, Fondamental Acad Centers Expertise Bipolar Disorder, Peggy Series, Raoul Belzeaux

Summary: This study investigates the relationship between different age cut-offs for early onset bipolar disorder (BD) and neurodevelopmental pathways. The results show that defining early onset as <=17 years best distinguishes neurodevelopmental patterns. These findings can improve patient stratification in future studies on BD pathophysiology and biomarkers.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychiatry

The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control study

Lucia Sideli, Monica Aas, Diego Quattrone, Daniele La Barbera, Caterina La Cascia, Laura Ferraro, Luis Alameda, Eva Velthorst, Giulia Trotta, Giada Tripoli, Adriano Schimmenti, Andrea Fontana, Charlotte Gayer-Anderson, Simona Stilo, Fabio Seminerio, Crocettarachele Sartorio, Giovanna Marrazzo, Antonio Lasalvia, Sarah Tosato, Ilaria Tarricone, Domenico Berardi, Giuseppe D'Andrea, Celso Arango, Manuel Arrojo, Miguel Bernardo, Julio Bobes, Julio Sanjuan, Jose Luis Santos, Paulo Rossi Menezes, Cristina Marta Del-Ben, Hannah E. Jongsma, Peter B. Jones, James B. Kirkbride, Pierre-Michel Llorca, Andrea Tortell, Baptiste Pignon, Lieuwe de Haan, Jean-Paul Selten, Jim Van Os, Bart P. Rutten, Richard Bentall, Marta Di Fort, Robin M. Murray, Craig Morgan, Helen L. Fisher

Summary: This study aimed to investigate whether the relationship between childhood maltreatment and cognition in patients with psychosis and community controls was influenced by genetic factors related to psychosis. The study included first-episode psychosis patients (N=755) and unaffected controls (N=1219) from the EU-GEI study, who were assessed for childhood maltreatment, intelligence quotient (IQ), family history of psychosis (FH), and polygenic risk score for schizophrenia (SZ-PRS). The results showed that controlling for FH and SZ-PRS did not weaken the association between childhood maltreatment and IQ in either cases or controls, suggesting that genetic liability factors do not explain the lower levels of cognition in adults who experienced childhood maltreatment.

SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2023)

Article Genetics & Heredity

Understanding the relationship between cerebellar structure and social abilities

Yannis Elandaloussi, Dorothea L. Floris, Pierrick Coupe, Edouard Duchesnay, Angeline Mihailov, Antoine Grigis, Indrit Begue, Julie Victor, Vincent Frouin, Marion Leboyer, Josselin Houenou, Charles Laidi

Summary: This study analyzed structural MRI data from a large pediatric and transdiagnostic sample and found a significant association between cerebellar volume and social difficulties. The results reveal a complex relationship between cerebellar structure, social performance, and IQ.

MOLECULAR AUTISM (2023)

Article Pharmacology & Pharmacy

Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs

Lea Darnaud, Clement Delage, Youssef Daali, Anne-Priscille Trouvin, Serge Perrot, Nihel Khoudour, Nadia Merise, Laurence Labat, Bruno Etain, Frank Bellivier, Celia Lloret-Linares, Vanessa Bloch, Emmanuel Curis, Xavier Decleves

Summary: Drug-metabolizing enzymes and drug transporters play crucial roles in drug pharmacokinetics and response. The cocktail-based phenotyping approach involves administering multiple probe drugs to evaluate the activities of CYP and transporter simultaneously. This study determined the range of phenotyping indices in healthy volunteers and classified patients with therapeutic issues based on CYP and P-gp activities.

PHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

The risk of hospitalization for psychotic disorders following hospitalization for COVID-19: a French nationwide longitudinal study

Baptiste Pignon, Valentina Decio, Philippe Pirard, Olivier Bouaziz, Emmanuelle Corruble, Pierre A. Geoffroy, Viviane Kovess-Masfety, Marion Leboyer, Cedric Lemogne, Jonathan Messika, Vittorio Perduca, Franck Schurhoff, Nolwenn Regnault, Sarah Tebeka

Summary: COVID-19 may not increase the risk of hospitalization for psychotic disorders, as patients initially hospitalized for COVID-19 had a lower rate of subsequent hospitalization for psychotic disorders compared to those initially hospitalized for other reasons. This finding contradicts the hypothesis that there is an increased risk of psychotic disorders after a severe COVID-19 infection. Importantly, a history of psychotic disorder was found to be a major determinant of hospitalization for psychotic disorders.

MOLECULAR PSYCHIATRY (2023)

Article Psychiatry

Accelerated aging in bipolar disorders: An exploratory study of six epigenetic clocks

Celine Bourdon, Bruno Etain, Luana Spano, Raoul Belzeaux, Marion Leboyer, Andree Delahaye-Duriez, El Cherif Ibrahim, Pierre-Eric Lutz, Sebastien Gard, Raymund Schwan, Mircea Polosan, Philippe Courtet, Christine Passerieux, Frank Bellivier, Cynthia Marie-Claire

Summary: In this study, accelerated epigenetic aging in individuals with BD was assessed using various DNA methylation-based markers. Different epigenetic clocks were found to be sensitive to different aspects of aging process in BD. The study also identified associations between age accelerations and body mass index, sex, smoking status, and childhood maltreatment.

PSYCHIATRY RESEARCH (2023)

Correction Genetics & Heredity

Understanding the relationship between cerebellar structure and social abilities (vol 14,18, 2023)

Yannis Elandaloussi, Dorothea L. L. Floris, Pierrick Coupe, Edouard Duchesnay, Angeline Mihailov, Antoine Grigis, Indrit Begue, Julie Victor, Vincent Frouin, Marion Leboyer, Josselin Houenou, Charles Laidi

MOLECULAR AUTISM (2023)

Article Neurosciences

Evolution of Cognitive Impairments in Treatment-Resistant Depression: Results from the Longitudinal French Centers of Expertise for Treatment-Resistant Depression (FACE-DR) Cohort

Alexis Vancappel, Yecodji Dansou, Ophelia Godin, Emmanuel Haffen, Antoine Yrondi, Florian Stephan, Raphaelle Marie Richieri, Fanny Moliere, Jerome Holtzmann, Mathilde Horn, Etienne Allauze, Jean Baptiste Genty, Alex Bouvard, Jean-Michel Dorey, Vincent Hennion, Vincent Camus, Guillaume Fond, Barbara Peran, Michel Walter, Loic Anguill, Charlotte Scotto D'apolina, Estelle Vila, Benjamin Fredembach, Jean Petrucci, Romain Rey, Anne Sophie Nguon, Bruno Etain, Mathilde Carminati, Philippe Courtet, Guillaume Vaiva, Pierre Michel Llorca, Marion Leboyer, Bruno Aouizerate, Djamila Bennabi, Wissam El Hage

Summary: This study examines the relationship between cognitive impairments and treatment response in patients with treatment-resistant depression. The findings suggest that cognitive scores improve after therapeutic response, with greater improvement observed in patients with better treatment response. Therefore, cognitive remediation should be provided after therapeutic response to enhance patients' daily functioning.

BRAIN SCIENCES (2023)

暂无数据